JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment

Provided By PR Newswire

Last update: Jul 10, 2024

-The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward-

-The company is intending a name and stock symbol change to reflect this decision-